United States Pharmaceuticals

Chiasma Inc (CHMA)

Track

Track

Ticker: CHMA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Mamluk Roni Non-Executive Director
Transaction date
Planned sale
Price
72.90
Quantity 10,201 +34.8%
Value US$2,770,307
2.9
STACK DAVID M Non-Executive Director
Transaction date
Purchase
Price
331.94
Quantity 12,982 +11.4%
Value US$4,417,826
KANNAN RAJ Chief Executive Officer Executive Director
Transaction date
Purchase
Price
346.35
Quantity 13,197 -16.3%
Value US$1,907,021
KANNAN RAJ Chief Executive Officer Executive Director
Transaction date
Purchase
Price
4.20
Quantity 10,000 +140.9%
Value US$42,000
Mamluk Roni Non-Executive Director
Transaction date
Planned sale
Price
4.54
Quantity 82,186 -100.0%
Value US$373,124
Mamluk Roni Non-Executive Director
Transaction date
Planned sale
Price
5.51
Quantity 61,139 -100.0%
Value US$336,876
Mamluk Roni
Transaction date
Planned sale
Price
4.94
Quantity 10,000 -100.0%
Value US$49,400
LUDLAM WILLIAM See Remarks
Transaction date
Purchase
Price
4.91
Quantity 5,050 +74.8%
Value US$24,783
Mamluk Roni
Transaction date
Planned sale
Price
5.59
Quantity 50,000 -100.0%
Value US$279,500
Minick Scott Non-Executive Director
Transaction date
Purchase
Price
5.33
Quantity 5,518 +6.8%
Value US$29,411
Minick Scott Non-Executive Director
Transaction date
Purchase
Price
5.02
Quantity 4,300 +5.6%
Value US$21,586
Mamluk Roni
Transaction date
Planned sale
Price
6.35
Quantity 10,000 -100.0%
Value US$63,500
Mamluk Roni
Transaction date
Planned sale
Price
5.31
Quantity 10,000 -100.0%
Value US$53,100
LUDLAM WILLIAM See Remarks
Transaction date
Planned purchase
Price
5.00
Quantity 1,625 +31.7%
Value US$8,125
Mamluk Roni
Transaction date
Planned sale
Price
5.00
Quantity 5,000 -100.0%
Value US$25,000
Mamluk Roni Non-Executive Director
Transaction date
Planned sale
Price
3.67
Quantity 5,000 -100.0%
Value US$18,370
Fitzpatrick Mark J. President and CEO Executive Director
Transaction date
Planned purchase
Price
2.50
Quantity 9,612 +inf%
Value US$24,030
Minick Scott Non-Executive Director
Transaction date
Purchase
Price
3.09
Quantity 13,000 +18.3%
Value US$40,170
Minick Scott Non-Executive Director
Transaction date
Purchase
Price
3.06
Quantity 8,000 +12.7%
Value US$24,480
Minick Scott Non-Executive Director
Transaction date
Purchase
Price
3.07
Quantity 4,000 +6.8%
Value US$12,280
Mamluk Roni Non-Executive Director
Transaction date
Planned sale
Price
1.46
Quantity 2,389 -100.0%
Value US$3,484
Mamluk Roni
Transaction date
Planned sale
Price
1.53
Quantity 2,389 -100.0%
Value US$3,655
Mamluk Roni
Transaction date
Planned sale
Price
1.75
Quantity 2,389 -100.0%
Value US$4,181
Mamluk Roni
Transaction date
Planned sale
Price
2.27
Quantity 2,389 -100.0%
Value US$5,430
Minick Scott
Transaction date
Purchase
Price
2.36
Quantity 10,000 +20.3%
Value US$23,569
Minick Scott
Transaction date
Purchase
Price
2.38
Quantity 15,000 +43.8%
Value US$35,690
7-MED Health Ventures LP Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 93,750 +inf%
Value US$1,500,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-02-11 2021-02-09 PlS Planned sale
Mamluk Roni
Non-Executive Director
10,201 +34.8%
72.90
US$2,770,307 		10,201 +34.8% 72.90 US$2,770,307
2020-12-01 2020-11-30 B Purchase
2.9
STACK DAVID M
Non-Executive Director
12,982 +11.4%
331.94
US$4,417,826 		12,982 +11.4% 331.94 US$4,417,826
2020-11-24 2020-11-23 B Purchase
KANNAN RAJ

Chief Executive Officer

Executive Director
13,197 -16.3%
346.35
US$1,907,021 		13,197 -16.3% 346.35 US$1,907,021
2020-07-15 2020-07-14 B Purchase
KANNAN RAJ

Chief Executive Officer

Executive Director
10,000 +140.9%
4.20
US$42,000 		10,000 +140.9% 4.20 US$42,000
2020-02-21 2020-02-20 PlS Planned sale
Mamluk Roni
Non-Executive Director
82,186 -100.0%
4.54
US$373,124 		82,186 -100.0% 4.54 US$373,124
2019-12-23 2019-12-20 PlS Planned sale Mamluk Roni Non-Executive Director
61,139 -100.0%
5.51
US$336,876 		61,139 -100.0% 5.51 US$336,876
2019-10-17 2019-10-16 PlS Planned sale
Mamluk Roni
10,000 -100.0%
4.94
US$49,400 		10,000 -100.0% 4.94 US$49,400
2019-09-27 2019-09-27 B Purchase
LUDLAM WILLIAM

See Remarks
5,050 +74.8%
4.91
US$24,783 		5,050 +74.8% 4.91 US$24,783
2019-09-23 2019-09-20 PlS Planned sale
Mamluk Roni
50,000 -100.0%
5.59
US$279,500 		50,000 -100.0% 5.59 US$279,500
2019-08-21 2019-08-20 B Purchase Minick Scott Non-Executive Director
5,518 +6.8%
5.33
US$29,411 		5,518 +6.8% 5.33 US$29,411
2019-08-21 2019-08-19 B Purchase Minick Scott Non-Executive Director
4,300 +5.6%
5.02
US$21,586 		4,300 +5.6% 5.02 US$21,586
2019-07-17 2019-07-16 PlS Planned sale
Mamluk Roni
10,000 -100.0%
6.35
US$63,500 		10,000 -100.0% 6.35 US$63,500
2019-04-17 2019-04-16 PlS Planned sale
Mamluk Roni
10,000 -100.0%
5.31
US$53,100 		10,000 -100.0% 5.31 US$53,100
2019-04-02 2019-04-01 PP Planned purchase
LUDLAM WILLIAM

See Remarks
1,625 +31.7%
5.00
US$8,125 		1,625 +31.7% 5.00 US$8,125
2019-03-06 2019-03-05 PlS Planned sale
Mamluk Roni
5,000 -100.0%
5.00
US$25,000 		5,000 -100.0% 5.00 US$25,000
2019-01-23 2019-01-22 PlS Planned sale
Mamluk Roni
Non-Executive Director
5,000 -100.0%
3.67
US$18,370 		5,000 -100.0% 3.67 US$18,370
2018-12-21 2018-12-20 PP Planned purchase Fitzpatrick Mark J.

President and CEO

Executive Director
9,612 +inf%
2.50
US$24,030 		9,612 +inf% 2.50 US$24,030
2018-09-20 2018-09-20 B Purchase Minick Scott Non-Executive Director
13,000 +18.3%
3.09
US$40,170 		13,000 +18.3% 3.09 US$40,170
2018-09-20 2018-09-19 B Purchase Minick Scott Non-Executive Director
8,000 +12.7%
3.06
US$24,480 		8,000 +12.7% 3.06 US$24,480
2018-09-20 2018-09-18 B Purchase Minick Scott Non-Executive Director
4,000 +6.8%
3.07
US$12,280 		4,000 +6.8% 3.07 US$12,280
2018-06-20 2018-06-18 PlS Planned sale Mamluk Roni Non-Executive Director
2,389 -100.0%
1.46
US$3,484 		2,389 -100.0% 1.46 US$3,484
2018-03-20 2018-03-19 PlS Planned sale Mamluk Roni
2,389 -100.0%
1.53
US$3,655 		2,389 -100.0% 1.53 US$3,655
2017-12-19 2017-12-18 PlS Planned sale Mamluk Roni
2,389 -100.0%
1.75
US$4,181 		2,389 -100.0% 1.75 US$4,181
2017-10-26 2017-10-24 PlS Planned sale Mamluk Roni
2,389 -100.0%
2.27
US$5,430 		2,389 -100.0% 2.27 US$5,430
2017-09-22 2017-09-21 B Purchase Minick Scott
10,000 +20.3%
2.36
US$23,569 		10,000 +20.3% 2.36 US$23,569
2017-09-22 2017-09-20 B Purchase Minick Scott
15,000 +43.8%
2.38
US$35,690 		15,000 +43.8% 2.38 US$35,690
2015-07-23 2015-07-21 B Purchase 7-MED Health Ventures LP Large shareholder
93,750 +inf%
16.00
US$1,500,000 		93,750 +inf% 16.00 US$1,500,000
Explore more

More insider trading research around Chiasma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America